Corbus Pharma (CRBP) Announces Proposed Public Common Offering

Related Posts

01Feb

Lions Industries employee receives special glasses

Teresa Harper shows off her eSight glasses at the Lions Industries for the Blind. Read more >> read more
07Jan

Pismo Ventures’ National Venture Plan Startup Competition Announces Winners

EcoSoul Home and SFA Therapeutics (1st place tie,) Eyedaptic (2nd place,) and Cooler Heads (3rd place) named as winners in... read more
31May

eSight Corp. Announces a new CEO and $10 Million in Funding

eSight, the leading vision-platform organization behind the world’s most advanced sight-enhancing glasses for the visually impaired, is pleased to announce... read more
08Jun

Emovi’s KneeKG Device Accepted to Smart Health Innovation Lab’s Certification Program, USA

Emovi, today announced that it has been selected to participate in a unique certification program at the newly-opened Smart Health... read more
19Jul

Three insights you might have missed from the ‘Secure Storage Hot Takes’ event

...During the recent “Secure Storage Hot Takes” event, cloud storage experts from Wasabi and The Hotchkiss School joined theCUBE’s industry... read more
07Nov

Startups win another $500,000 from Boeing and CASIS for zero-gravity tech

Eleven startups in all have benefited from the “Technology in Space” prizes awarded since 2014 at MassChallenge Boston, with backing... read more
08Jun

Smart glasses give legally blind man second chance to see his wife at their wedding

A pair of eSight 3 smart glasses have given Airey something close to 20/20 vision. Recently Airey and his family... read more
09Mar

Siamab Therapeutics Announces Publication of New Preclinical Data

Siamab Therapeutics, Inc., a biopharmaceutical company developing novel cancer immunotherapies, today announced the publication of new preclinical data describing its... read more
18Jan

Myomo® to Present at Noble Capital Markets’ 15th Annual Investor Conference

Myomo, Inc., a wearable medical robotics company, today announced that it will be presenting at NobleCon15 - Noble Capital Markets’... read more
14May

CytoAgents Receives NIH Funding to Accelerate Treatment for Cytokine Storm

CytoAgents awarded $1.6 million National Institutes of Health (NIH) grant to accelerate treatment for cytokine storm. Read more >> read more